This suggests that, in addition to mutp53 reduction, wtp53 reactivation contributed to the down-regulation of CHK1 and RAD51 observed in the HDACi-treated pancreatic cancer cells. The gene discussed is RAD51; the disease is pancreatic neoplasm.